Choroidal Neovascularization in Pediatric Population

  • Şengül Özdek
  • Hatice Tuba Atalay


Choroidal neovascularization (CNV) is quite rare in children and adolescents. In this young population, CNV has been reported in association with infection, inflammation, optic disc anomalies, retinal dystrophies, disruption of Bruch’s membrane, choroidal tumors, and trauma. Often, no cause is found and the CNV is said to be idiopathic (Sivaprasad and Moore, Br J Ophthalmol 92(4):451–454, 2008; Goshorn et al., J Pediatr Ophthalmol Strabismus 32(3):178–182, 1995; Spaide, Curr Opin Ophthalmol 10:177–181, 1999). Laser photocoagulation, photodynamic therapy with verteporfin, and submacular surgery have been employed successfully for the treatment of pediatric CNVs. However, anti-VEGF therapy and PDT remains the preferred treatment options.


Choroidal neovascularization Children Best’s vitelliform macular dystrophy Photodynamic therapy Anti-vascular endothelial growth factor 


  1. 1.
    Sivaprasad S, Moore AT. Choroidal neovascularisation in children. Br J Ophthalmol. 2008;92(4):451–4.PubMedCrossRefGoogle Scholar
  2. 2.
    Goshorn EB, Hoover DL, Eller AW, Friberg TR, Jarrett WH, Sorr EM. Subretinal neovascularization in children and adolescents. J Pediatr Ophthalmol Strabismus. 1995;32(3):178–82.PubMedGoogle Scholar
  3. 3.
    Spaide RF. Choroidal neovascularization in younger patients. Curr Opin Ophthalmol. 1999;10:177–81.PubMedCrossRefGoogle Scholar
  4. 4.
    Wilson ME, Mazur DO. Choroidal neovascularization in children: report of five cases and literature review. J Pediatr Ophthalmol Strabismus. 1988;25(1):23–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Prasad AG, Van Gelder RN. Presumed ocular histoplasmosis syndrome. Curr Opin Ophthalmol. 2005;16(6):364–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Mavrikakis E, Levin AV, Lam WC. Choroidal neovascularization secondary to congenital toxoplasmosis in an infant. Can J Ophthalmol. 2010;45(6):e11–2.PubMedCrossRefGoogle Scholar
  7. 7.
    Ketata A, Ben Zina Z, Hajji D, Sellami D, Abdelkefi A, Kharrat W, et al. Two cases of subretinal neovascular membrane in Vogt-Koyanagi-Harada syndrome. J Fr Ophtalmol. 2006;29(3):302–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Ozdek S, Ozmen MC, Tufan HA, Gurelik G, Hasanreisoglu B. Photodynamic therapy for best disease complicated by choroidal neovascularization in children. J Pediatr Ophthalmol Strabismus. 2012;49(4):216–21.PubMedGoogle Scholar
  9. 9.
    Secretan M, Sickenberg M, Zografos L, Piguet B. Morphometric characteristics of traumatic choroidal ruptures associated with neovascularization. Retina. 1998;18:62–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Patel MM, Chee YE, Eliott D. Choroidal rupture: a review. Int Ophthalmol Clin. 2013;53(4):69–78.PubMedCrossRefGoogle Scholar
  11. 11.
    Tilleul J, Mimoun G, Querques G, Puche N, Zerbib J, Lalloum F, et al. Intravitreal ranibizumab for choroidal neovascularization in angioid streaks: four year follow-up. Retina. 2016;36(3):483–91.PubMedCrossRefGoogle Scholar
  12. 12.
    Rishi P, Gupta A, Rishi E, Shah BJ. Choroidal neovascularization in 36 eyes of children and adolescents. Eye (Lond). 2013;27(10):1158–68.CrossRefGoogle Scholar
  13. 13.
    Potter MJ, Szabo SM, Ho T. Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl. Graefes Arch Clin Exp Ophthalmol. 2006;244(5):639–41.PubMedCrossRefGoogle Scholar
  14. 14.
    Secretan M, Kuhn D, Soubrane G, Coscas G. Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. Eur J Ophthalmol. 1997;7:307–16.PubMedCrossRefGoogle Scholar
  15. 15.
    Erkkilä H. Clinical appearance of optic disc drusen in childhood. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975;193(1):1–18.PubMedCrossRefGoogle Scholar
  16. 16.
    Basdekidou C, Caputo G. Optic nerve abnormalities in pediatric ocular diseases. In: Hartnett ME, Trese M, Capone A, BJB K, Steidl SM, editors. Pediatric retina. 2nd ed. Philadelphia: Wolters Kluver, Lippincott Williams & Wilkins; 2014. p. 148–72.Google Scholar
  17. 17.
    Daruich AL, Moulin AP, Tran HV, Matet A, Munier FL. Subfoveal nodule in Coats’ disease: toward an updated classification predicting visual prognosis. Retina. 2017;37(8):1591–8.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Shields CL, Sun H, Demirci H, Shields JA. Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma. Arch Ophthalmol. 2005;123(12):1658–66.PubMedCrossRefGoogle Scholar
  19. 19.
    Hollander DA, Stewart JM. Acquired and other retinal diseases. In: Lambert SR, Lyons CJ, editors. Taylor & Hoyt’s pediatric ophthalmology and strabismus. 4th ed. Philadelphia: Elsevier; 2013. p. 522–9.CrossRefGoogle Scholar
  20. 20.
    Lupidi M, Cerquaglia A, Chhablani J, Fiore T, Singh SR, Cardillo Piccolino F, et al. Optical coherence tomography angiography in age-related macular degeneration: the game changer. Eur J Ophthalmol. 2018;28(4):349–57.PubMedCrossRefGoogle Scholar
  21. 21.
    Sodi A, Murro V, Caporossi O, Passerini I, Bacci GM, Caputo R, et al. Long-term results of photodynamic therapy for choroidal neovascularization in pediatric patients with best Vitelliform Macular Dystrophy. Ophthalmic Genet. 2015;36(2):168–74.PubMedCrossRefGoogle Scholar
  22. 22.
    Sears J, Capone A Jr, Aaberg T Sr, Lewis H, Grossniklaus H, Sternberg P Jr, et al. Surgical management of subfoveal neovascularization in children. Ophthalmology. 1999;106(5):920–4.PubMedCrossRefGoogle Scholar
  23. 23.
    Uemura A, Thomas MA. Visual outcome after surgical removal of choroidal neovascularization in pediatric patients. Arch Ophthalmol. 2000;118(10):1373–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Kohly RD, Muni RH, Kertes PJ, Lam WC. Management of pediatric choroidal neovascular membranes with intravitreal anti-VEGF agents: a retrospective consecutive case series. Can J Ophthalmol. 2011;46:46–50.PubMedCrossRefGoogle Scholar
  25. 25.
    Rich R, Vanderveldt S, Berrocal AM, Mavrofrides EC, Murray TG, Gregori N. Treatment of choroidal neovascularization associated with Best’s disease in children. J Pediatr Ophthalmol Strabismus. 2009;46:306–11.PubMedCrossRefGoogle Scholar
  26. 26.
    Baillif S, Nguyen E, Colleville-El Hayek A, Betis F. Long term follow-up after single intravitreal ranibizumab injection for choroidal neovascularization secondary to optic nerve head drusen in a 5-year old child. Graefes Arch Clin Exp Ophthalmol. 2013;251:1657–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Vayalambrone D, Misra A. Paediatric choroidal osteoma treated with ranibizumab. BMJ Case Rep. 2012;
  28. 28.
    Benevento J, Jager RD, Noble AG, Latkany P, Mieler WF, Sautter M, et al. Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol. 2008;126:1152–6.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Piermarocchi S, Benetti E, Fracasso G. Intravitreal bevacizumab for posttraumatic choroidal neovascularization in a child. J AAPOS. 2011;15:314–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Henry CR, Sisk RA, Tzu JH, Albini TA, Davis JL, Murray TG, et al. Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric retinal and choroidal diseases. J AAPOS. 2015;19(6):541–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Kozak I, Mansour A, Diaz RI, Calzada JI, Pichi F, Cruz-Villegas V, et al. Outcomes of treatment of pediatric choroidal neovascularization with intravitreal antiangiogenic agents. Retina. 2014;34:2044–52.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Şengül Özdek
    • 1
  • Hatice Tuba Atalay
    • 1
  1. 1.Ophthalmology DepartmentGazi University Medical SchoolAnkaraTurkey

Personalised recommendations